Literature DB >> 10588972

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

B L Herwaldt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10588972     DOI： 10.1056/NEJM199912093412411

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.

Authors:  S Sundar; G Agrawal; M Rai; M K Makharia; H W Murray
Journal:  BMJ       Date:  2001-08-25

Review 3.  Laboratory-acquired parasitic infections from accidental exposures.

Authors:  B L Herwaldt
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Miltefosine (Impavido): the first oral treatment against leishmaniasis.

Authors:  H Sindermann; S L Croft; K R Engel; W Bommer; H J Eibl; C Unger; J Engel
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

5.  Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis.

Authors:  Adriana Oliveira Dos Santos; Phercyles Veiga-Santos; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Daniela Bueno Sudatti; Everson Miguel Bianco; Renato Crespo Pereira; Celso Vataru Nakamura
Journal:  Mar Drugs       Date:  2010-10-29       Impact factor: 5.118

6.  Possible mechanism of miltefosine-mediated death of Leishmania donovani.

Authors:  Navin K Verma; Chinmoy S Dey
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Authors:  Malika Larabi; Vanessa Yardley; Philippe M Loiseau; Martine Appel; Philippe Legrand; Annette Gulik; Christian Bories; Simon L Croft; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

8.  Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.

Authors:  Anny Fortin; Diana P Caridha; Susan Leed; Franklyn Ngundam; Jenell Sena; Tom Bosschaerts; Sandi Parriott; Mark R Hickman; Thomas H Hudson; Max Grogl
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11

9.  Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes.

Authors:  S W Kamau; R Nunez; F Grimm
Journal:  BMC Pharmacol       Date:  2001-04-05

10.  Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response.

Authors:  Anja Kathrin Wege; Christian Florian; Wolfgang Ernst; Nicole Zimara; Ulrike Schleicher; Frank Hanses; Maximilian Schmid; Uwe Ritter
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.